Combined 17alpha-Hydroxylase/17,20-lyase deficiency caused by Phe93Cys mutation in the CYP17 gene. 2002

Alfredo Di Cerbo, and Anna Biason-Lauber, and Maria Savino, and Maria Rosaria Piemontese, and Anna Di Giorgio, and Marco Perona, and Anna Savoia
Division and Research Unit of Endocrinology and Department of Medical Genetics, Istituto di Ricovero e Cura a Carattere Scientifico Ospedale "Casa Sollievo della Sofferenza," 71013 San Giovanni Rotondo, Italy. adicerb@tin.it

Seventeen alpha-hydroxylase/17,20-lyase deficiency is a rare, autosomal recessive form of congenital adrenal hyperplasia not linked to human leukocyte antigen and characterized by the coexistence of hypertension caused by the hyperproduction of mineralocorticoid precursors and sexual abnormalities, such as male pseudohermaphroditism and sexual infantilism in female, due to impaired production of sex hormones. Both 17alpha-hydroxylase and 17,20-lyase reactions are catalyzed by a single polypeptide, cytochrome P450c17 (CYP17), which is encoded by the CYP17 gene located on chromosome 10q24-q25. Mutations in the CYP17 gene have been recognized to cause the 17alpha-hydroxylase/17,20-lyase deficiency syndrome. Here, we describe two phenotypically and hormonally affected Italian patients with 17alpha-hydroxylase/17,20-lyase deficiency. The family history revealed consanguinity of the parents. Linkage and haplotype analyses using microsatellites on chromosome 10q24-q25 demonstrated that the two affected individuals were homozygous at these loci. The mutation screening of the CYP17 gene identified a new Phe93Cys missense mutation in exon 1. The amino acid substitution is located in a highly conserved region of the protein and is not a polymorphism because it is not present in one hundred normal alleles. In vitro functional studies showed that the Phe93Cys mutated CYP17 retains only 10% of both 17alphahydroxylase and 17,20-lyase activities, according to the severe phenotype. Our results shed more light on the structure-function relationship of the CYP17 protein indicating that Phe 93 is crucial for both enzymatic activities.

UI MeSH Term Description Entries
D008297 Male Males
D008659 Metabolic Diseases Generic term for diseases caused by an abnormal metabolic process. It can be congenital due to inherited enzyme abnormality (METABOLISM, INBORN ERRORS) or acquired due to disease of an endocrine organ or failure of a metabolically important organ such as the liver. (Stedman, 26th ed) Thesaurismosis,Diseases, Metabolic,Disease, Metabolic,Metabolic Disease,Thesaurismoses
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D010375 Pedigree The record of descent or ancestry, particularly of a particular condition or trait, indicating individual family members, their relationships, and their status with respect to the trait or condition. Family Tree,Genealogical Tree,Genealogic Tree,Genetic Identity,Identity, Genetic,Family Trees,Genealogic Trees,Genealogical Trees,Genetic Identities,Identities, Genetic,Tree, Family,Tree, Genealogic,Tree, Genealogical,Trees, Family,Trees, Genealogic,Trees, Genealogical
D003907 Dexamethasone An anti-inflammatory 9-fluoro-glucocorticoid. Hexadecadrol,Decaject,Decaject-L.A.,Decameth,Decaspray,Dexasone,Dexpak,Hexadrol,Maxidex,Methylfluorprednisolone,Millicorten,Oradexon,Decaject L.A.
D005260 Female Females
D005938 Glucocorticoids A group of CORTICOSTEROIDS that affect carbohydrate metabolism (GLUCONEOGENESIS, liver glycogen deposition, elevation of BLOOD SUGAR), inhibit ADRENOCORTICOTROPIC HORMONE secretion, and possess pronounced anti-inflammatory activity. They also play a role in fat and protein metabolism, maintenance of arterial blood pressure, alteration of the connective tissue response to injury, reduction in the number of circulating lymphocytes, and functioning of the central nervous system. Glucocorticoid,Glucocorticoid Effect,Glucorticoid Effects,Effect, Glucocorticoid,Effects, Glucorticoid
D006728 Hormones Chemical substances having a specific regulatory effect on the activity of a certain organ or organs. The term was originally applied to substances secreted by various ENDOCRINE GLANDS and transported in the bloodstream to the target organs. It is sometimes extended to include those substances that are not produced by the endocrine glands but that have similar effects. Hormone,Hormone Receptor Agonists,Agonists, Hormone Receptor,Receptor Agonists, Hormone

Related Publications

Alfredo Di Cerbo, and Anna Biason-Lauber, and Maria Savino, and Maria Rosaria Piemontese, and Anna Di Giorgio, and Marco Perona, and Anna Savoia
July 2005, The Journal of clinical endocrinology and metabolism,
Alfredo Di Cerbo, and Anna Biason-Lauber, and Maria Savino, and Maria Rosaria Piemontese, and Anna Di Giorgio, and Marco Perona, and Anna Savoia
June 2006, The Journal of clinical endocrinology and metabolism,
Alfredo Di Cerbo, and Anna Biason-Lauber, and Maria Savino, and Maria Rosaria Piemontese, and Anna Di Giorgio, and Marco Perona, and Anna Savoia
April 2003, Metabolism: clinical and experimental,
Alfredo Di Cerbo, and Anna Biason-Lauber, and Maria Savino, and Maria Rosaria Piemontese, and Anna Di Giorgio, and Marco Perona, and Anna Savoia
August 2009, The Journal of clinical endocrinology and metabolism,
Alfredo Di Cerbo, and Anna Biason-Lauber, and Maria Savino, and Maria Rosaria Piemontese, and Anna Di Giorgio, and Marco Perona, and Anna Savoia
November 2002, European journal of biochemistry,
Alfredo Di Cerbo, and Anna Biason-Lauber, and Maria Savino, and Maria Rosaria Piemontese, and Anna Di Giorgio, and Marco Perona, and Anna Savoia
February 2008, Journal of pediatric endocrinology & metabolism : JPEM,
Alfredo Di Cerbo, and Anna Biason-Lauber, and Maria Savino, and Maria Rosaria Piemontese, and Anna Di Giorgio, and Marco Perona, and Anna Savoia
February 2010, Metabolism: clinical and experimental,
Alfredo Di Cerbo, and Anna Biason-Lauber, and Maria Savino, and Maria Rosaria Piemontese, and Anna Di Giorgio, and Marco Perona, and Anna Savoia
December 1998, Neurology,
Alfredo Di Cerbo, and Anna Biason-Lauber, and Maria Savino, and Maria Rosaria Piemontese, and Anna Di Giorgio, and Marco Perona, and Anna Savoia
November 2010, Arquivos brasileiros de endocrinologia e metabologia,
Alfredo Di Cerbo, and Anna Biason-Lauber, and Maria Savino, and Maria Rosaria Piemontese, and Anna Di Giorgio, and Marco Perona, and Anna Savoia
November 2005, The Journal of steroid biochemistry and molecular biology,
Copied contents to your clipboard!